David D. Gruberg: Lawyer with Greenberg Traurig, LLP

David D. Gruberg

Miami,  FL  U.S.A.

Peer Rating

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials

Practice Areas

  • Corporate & Securities
  • Emerging Technology
  • Private Equity
  • Life Sciences & Medical Technology
  • Mergers & Acquisitions
Contact InfoTelephone: 305.579.0630
Fax: 305.961.5829
University La Salle University, B.S., Finance, maxima cum laude, Minor in International Studies, 2007 Beta Gamma Sigma International Business Honor Society, William McGowan Scholar, School of Business
Law SchoolUniversity of Miami School of Law, J.D., summa cum laude, 2011 Order of the Coif, Executive Editor, University of Miami Law Review
Admitted2011, Florida

Professional & Community Involvement

•Member, American Bar Association


David D. Gruberg focuses his practice on assisting private and public companies with general corporate and transactional matters, including venture capital and private equity investment and formation matters, public offerings and private placements, mergers and acquisitions, securities reporting compliance, and corporate governance issues.

Awards & Recognition
•Team Member, Corporate Board Member magazine and FTI Consulting Inc., one of America's Best Corporate Law Firms, 13th Annual Legal Industry Study, 2013
•Member, team ranked as a top corporate law firm in Miami as selected by corporate directors, in the annual Legal Industry Research Study by Corporate Board Member magazine and FTI Consulting Inc. (10th year), 2002-2009, 2011-2012

Legal Experience
•Summer Associate, Florida based corporate law firm, Fort Lauderdale, FL (May 2010 - August 2010)
•Clinical Student, Federal Appellate Clinic, United States Court of Appeals for the Eleventh Circuit, Miami, FL (January 2010 - May 2010)

Previous Employment
•Information Technology Consultant, CGI, Technologies and Solutions, Inc., New York, NY (January 2008 - June 2008)

Articles, Publications, & Lectures
•Mentioned, Greenberg's Davis Guides Cross-Border Acquisition, Daily Business Review, April 29, 2014
•Cited, Jerry W. Markham, Law Enforcement and the History of Financial Market Manipulation, 2013
•Cited, Thomas Lee Hazen, Treatise on the Law of Securities Regulation, 12.17. Insider Trading and Rule 10b-5, 2013
•Cited, Thomas Lee Hazen, Treatise on the Law of Securities Regulation, 14.3. Regulation of Broker-Dealers-The SEC, Self-Regulatory Organizations, National Exchanges, and FINRA, 2013
•Mentioned, Infrastructure Company Gets Cash to Grow on with Greenberg Traurig Help, Daily Business Review, April 17, 2013
•Cited, Jasmin Sethi, Another Role for Securities Regulation: Expanding Investor Opportunity, 16 Fordham J. Corp. & Fin. L. 783, 806, 2011
•Author, Decent Exposure: The SEC's Lack of Authority and Restraint in Proposing to Eliminate Flash Trading, 65 U. Miami L. Rev. 263, 2010

Associated News & Events
Press Releases
Greenberg Traurig Miami Represents MasTec, Inc. in Connection with Issuance of $400 million of 4.875% Senior Notes
Greenberg Traurig LLP Represents Amaya Gaming Group in its $167 Million Acquisition of Cadillac Jack, Inc.
Greenberg Traurig Listed as a Top Corporate Firm for the 10th Time in Corporate Board Member magazine

Reported CasesSignificant Representations; Represented a private equity fund in the purchase of a Swedish publicly traded global IT security vendor focused on cybersecurity and a U.S.-based provider of automated content compliance solutions and their strategic merger and restructuring. Represented Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD), an Israeli biopharmaceutical company, in its initial public offering on the Nasdaq Capital Market. Represented a private equity fund in an investment in a high growth provider of anti-fraud solutions through a single integrated platform primarily for the banking industry, including leading Latin American financial institutions. Represented a private equity fund in a majority investment in and loan to a leading provider of network security and compliance products for virtual environments. Represented a private equity fund in an investment in a provider of intelligent semantic software. Represented an NYSE-listed international infrastructure company in the purchase of a provider of data and cell tower services. Represented MasTec, Inc. in its $400 million public offering of 4.875% Senior Notes. Represented an NYSE-listed national medical group in connection with its $500 million and $800 million unsecured revolving credit facilities. Represented an advanced clinical-stage biopharmaceutical company with the listing of its Level II American Depositary Receipts (ADRs) on the NYSE MKT. Represented a private equity fund in an investment in a provider of DDoS detection, prevention and mitigation services to protect internet operations from service disruption. Represented an internet-based media and entertainment company with the sale of $150 million of intellectual property and other assets. Assisted in the representation of Amaya Gaming Group in its $167 million acquisition of Cadillac Jack, Inc. Assisted with the restructuring and sale of a multi-therapeutic provider of clinical research services for drug development to a worldwide provider of preclinical and clinical research services to pharmaceutical and biotechnology clients. Assisted with the $46 million sale of a digital entertainment services company. Represented a private-equity fund in its investment in a specialty pharmaceutical and health care service provider. Represented an NYSE-listed international infrastructure company in its $70 million acquisition of a provider of oil and gas pipeline and plant construction services. Represented an Israeli private equity fund in its sale of a provider of integrated software and technology solutions for health care providers. Represented a private equity fund in its sale of an asset-based lending business to a strategic investor. Represented an Israeli biopharmaceutical company in a reverse triangular merger with a NASDAQ OMX First North Premier traded biopharmaceutical company. Ongoing representation of several NYSE, NYSE MKT and Nasdaq-traded public companies.
Profile Visibility
#1,006 in weekly profile views out of 10,898 lawyers in Miami, Florida
#114,561 in weekly profile views out of 1,648,112 total lawyers Overall

Office Information

David D. Gruberg

333 SE 2nd Avenue, Suite 4400
MiamiFL 33131


Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now